Telix Pharmaceuticals Announces Board Change and Shareholding
Company Announcements

Telix Pharmaceuticals Announces Board Change and Shareholding

Telix Pharmaceuticals Ltd. (AU:TLX) has released an update.

Telix Pharmaceuticals Ltd. announced the departure of Dr. Andreas Kluge from its board, effective October 17, 2024. Dr. Kluge, through Gnosis Verwaltungsgesellschaft m.b.H, holds 22,675,000 fully paid ordinary shares, indicating significant past involvement with the company. This change may influence investor perceptions and future strategic directions for Telix.

For further insights into AU:TLX stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskTelix Pharmaceuticals Gains from New CMS Reimbursement Policy
TipRanks Australian Auto-Generated NewsdeskTelix Pharmaceuticals Gains FDA Priority Review for Cancer Imaging Agent
TipRanks Australian Auto-Generated NewsdeskTelix Pharmaceuticals to Release Shares from Escrow
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App